Translational Research Integration & Support
Streamline multi-institutional cancer research through a one-stop platform for study delivery, molecular profiling, data analytics and biomarker discovery.
STCC's Translational Research Integration & Support platform serves as a one-stop partner for translational and pre-clinical cancer research in Singapore. We connect healthcare institutions, researchers, research institutes and industry partners through an integrated end-to-end research pipeline, enabling faster study execution, biomarker discovery, molecular profiling and clinical translation.
From study design and governance to biospecimen access, advanced molecular analyses and multi-omics data integration, we simplify complex multi-institutional projects and transform promising research ideas into impactful scientific and clinical outcomes.
_AdobeStock_2088886639.jpeg)
Why Partner With STCC
Cancer research often requires navigating multiple institutions, systems and technologies. STCC acts as a single coordinating partner, bringing together the expertise, resources and infrastructure needed to accelerate translational cancer research. Through STCC, partners gain access to:
National Research Network
Access coordinated expertise, patient cohorts and research capabilities across Singapore's leading healthcare institutions and cancer research centres.
End-to-End Research Delivery
Streamline study start-up, governance, biospecimen access and project execution through dedicated translational research and project management support.
Advanced Molecular Profiling
Leverage cutting-edge genomics, spatial biology and multi-omics technologies to drive biomarker discovery and translational research outcomes.
Integrated Data & Analytics
Combine clinical, pathology and molecular data with advanced analytics to generate actionable insights and accelerate precision oncology.
End-to-End Translational Research Pipeline
STCC delivers a comprehensive translational research pathway that supports projects from conception through to discovery, validation and translation.
Key Focus Areas
Accelerating translational cancer research through integrated molecular profiling, clinically relevant tumour models, and advanced data analytics. By connecting samples, technologies and insights, STCC enables discovery, validation and the translation of research into patient impact.
Cancer Tissue Profiling
Comprehensive molecular characterisation of patient samples to support biomarker discovery, treatment response analysis and precision oncology research.
View our Molecular Assay Catalogue
Patient-Derived Organoid Models
Clinically relevant tumour models that enable drug screening, disease modelling and translational research using Asian-centric cancer cohorts.
View our DIVERSITY Organoid Catalogue
Integrated Research Data & Analytics
Secure integration of clinical, molecular and research data to generate actionable insights through advanced analytics and collaborative research.
What Our Platform Enables
✓ Biomarker discovery
Identify and validate novel biomarkers from multi-omic datasets across tumour types
✓ Companion Diagnostic Development
Develop and validate CDx assays in alignment with therapeutic programmes
✓ Pre-clinical Drug Screening
Ex vivo efficacy and toxicity testing using patient-derived organoid models
✓ Disease Modelling
Generate and characterise complex organoid models for mechanistic and translational studies
Ready to Accelerate Your Research?
Connect with STCC to streamline complex research projects, access national capabilities and accelerate translational cancer research.